Clinical Research Forum 2017

ACTide by Nubilaria is exhibiting at the unique discussing platform for the clinical research industry in Eastern Europe, November 9 – 10, 2017 – Kiev, Ukraine.

The 1st Kiev Clinical Forum brings together international experts from industry, regulatory agencies, academia and non-profit boards to share views and knowledge on clinical research among all the participants, providing awesome networking opportunities and adequate discussion between speakers and audience.


The Forum is organized by PharmaSich, the Ukrainian Life Sciences company, representing Ukraine in EUCROF.


The conference is held under the patronage of the European CRO Federation (EUCROF), the largest European non-profit CRO association.

Who should attend?

  • Sponsors, CROs and Clinical Trial Vendors
  • Clinical Operations
  • Clinical Development
  • Scientific & Medical Affairs
  • Regulatory Specialists
  • Clinical Purchasing & Outsourcing
  • Clinical Quality Assurance
  • Business Development

The conference will be considering the topics:

  • Implementation roadmap for ICH E6 (R2)
  • Risk-based approaches to clinical trials
  • Regulations (EU, Ukraine)
  • Regional focus (Ukraine, Albania)
  • Clinical Operations
  • Medical Affairs & Clinical Development
  • Innovations transforming clinical trials

Why we attend?

  • 300 delegates from all over the world
  • Excellent networking in the friendly atmosphere
  • Meaningful presentations from the best industry experts
  • Interactive roundtable discussions on the actual topics

Book Now!


ACTide - request a demo

Latest news

ACTide by Nubilaria against COVID-19

DECEIVER trial for COVID-19 related ARDS intensive care

Read more
Nubilaria for EUROLogin2020


Read more
Nubilaria ACTide @ SCOPE Virtual 2021

SCOPE – Summit for Clinical Ops Executives

Read more
Nubilaria Christmas wishes 2020

Merry Christmas and Happy new Year

Read more

Want more information about our solutions?
Contact us today.

I've read and accept theTerms and Conditions and the Privacy Policy
   I would like to receive information about products and services via traditional mail, telephone, email and automated communication systems